THE CLINICAL AND PATHOPHYSIOLOGICAL FEATURES OF ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME

Download full text PDF
Issue: 
2
Year: 
2017

Professor Zh. Mironova, MD; E. Vsevolodskaya; V. Belash; Professor V. Trofimov, MD; A. Ulitina, Candidate of Medical Sciences; S. Pchelina, Biol.D; Professor M. Dubina, MD, Academician of the Russian Academy of Sciences; S. Gorbunkov, Candidate of Medical Sciences; Professor A. Akopov, MD Acad. I.P. Pavlov First Saint Petersburg State Medical University

In clinical practice, asthma and chronic obstructive pulmonary disease (COPD) are easily distinguishable; however, the asthma-COPD overlap syndrome (OS) in a patient causes both diagnostic and therapeutic challenges. The phenotype of the asthma-COPD OS is characterized by a worse prognosis than that of isolated diseases of asthma or COPD. OS is characterized by a concurrence of eosinophilic and neutrophilic inflammation in the respiratory tract, which is accompanied by obvious obstruction of the distal bronchi and bronchospasm. Patients with OS are a population different from those with asthma or COPD; and the identification of such persons into a special group is justified and appropriate in the context of pathophysiology, clinical presentations, and therapy.
Keywords: 
asthma
chronic obstructive pulmonary disease
overlap syndrome

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Menezes A., de Oca M., Perez-Padilla R. et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma // Chest. – 2014; 145: 297–304.
  2. Chung J., Ae Kong K., Lee J. et al. Characteristics and self-rated health of overlap syndrome // Int. J. COPD. – 2014; 9: 795–804.
  3. Kelly A., Bowen H., Jee Y. et al. The glucocorticoid receptor beta isoform can mediate transcriptional repression by recruiting histone deacetylases // J. Allergy Clin. Immunol. – 2008; 121 (1): 203.
  4. Pleasants R., Ohar J., Croft J. et al. Chronic obstructive pulmonary disease and asthma: patient characteristics and health impairment // COPD. – 2014; 11: 256–66.
  5. Sharma S., Chhabra D., Kho A. et al. The genomic origins of asthma // Thorax. – 2014; 69 (5): 481–7.
  6. Galban C., Han M., Boes J. et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression // Nat. Med. – 2012; 18 (11): 1711–5.
  7. Soler-Cataluna J., Cosio B., Izquierdo J. et al. Consensus document on the overlap phenotype COPD-asthma in COPD // Arch. Bronconeumol. – 2012; 48 (9): 331–7.
  8. Contoli M., Baraldo S., Marku B. et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up // J. Allergy Clin. Immunol. – 2010; 125 (4): 830–7.
  9. Soriano J., Davis K., Coleman B. et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom // Chest. – 2003; 124 (2): 474–81.
  10. Hardin M., Silverman E., Barr R. et al. The clinical features of the overlap between COPD and asthma // Respir. Res. – 2011; 12: 127.
  11. Miravitlles M., Soriano J., Ancochea J. et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status // Respir. Med. – 2013; 107: 1053–60.
  12. Shaya F., Dongyi D., Akazawa M. et al. Burden of concomitant asthma and COPD in a Medicaid population // Chest. – 2008; 134 (1): 14–9.
  13. Weatherall M., Travers J., Shirtcliffe P. et al. Distinct clinical phenotypes of airways disease defined by cluster analysis // Eur. Respir. J. – 2009; 34 (4): 812–8.
  14. Guerra S. Overlap of asthma and chronic obstructive pulmonary disease // Curr. Opin. Pulm. Med. – 2005; 11 (1): 7–13.
  15. Buist A. Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes // Eur. Respir. J. Suppl. – 2003; 39: 30–5.
  16. Kauppi P., Kupiainen H., Lindqvist A. et al. Overlap syndrome of asthma and COPD predicts low quality of life // J. Asthma. – 2011; 48 (3): 279–85.
  17. GINA-GOLD. Diagnosis of disease of chronic airflow limitation: asthma, COPD and asthma-COPD overlap syndrome (ACOS), 2014.
  18. Postma D., Reddel H., ten Hacken N. et al. Asthma and chronic obstructive pulmonary disease: similarities and differences // Clin. Chest. Med. – 2014; 35: 143–56.
  19. Louie S., Zeki A., Schivo M. et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations // Expert Rev. Clin. Pharmacol. – 2013; 6: 197–219.
  20. Nakawah M., Hawkins C., Barbandi F. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome // J. Am. Board. Fam. Med. – 2013; 26 (4): 470–7.
  21. Louie S., Zeki A., Schivo M. et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations // Expert Rev. Clin. Pharmacol. – 2013; 6: 197–219.
  22. Agler A., Crystal R., Mezey J. et al. Differential expression of vitamin E and selenium-responsive genes by disease severity in chronic obstructive pulmonary disease // COPD. – 2013; 10: 450–8.
  23. Gibson P., Simpson J. The overlap syndrome of asthma and COPD: what are its features and how important is it? // Thorax. – 2009; 64: 728–35.
  24. Nakawah M., Hawkins C., Barbandi F. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome // J. Am. Board. Fam. Med. – 2014; 26: 470–7.
  25. Papaiwannou A., Zarogoulidis P., Porpodis K. et al. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review // J. Thorac. Dis. – 2014; 6 (Suppl. 1): 146–51.
  26. Papaiwannou A., P., Porpodis K. et al. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review // Int. J. Pharm. – 2014; 461: 411–8.
  27. Iwamoto H., Gao J., Koskela J. et al. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap // Eur. Respir. J. – 2014; 43: 421–9